Factors
Entities
Byram RiverAnaphylaxisPericarditisYellow Card SchemeImmunologyHeart failureMedicines and Healthcare products Regulatory AgencyJasonFacial nerve paralysisThrombosisInflammationClinical trialParamount NetworkMyocarditisUniversity of OxfordAstraZenecaFood and Drug AdministrationCenters for Disease Control and PreventionChief executive officerPfizerUnited KingdomVaccineSevere acute respiratory syndrome coronavirus 2Full FactNuffield TrustAdverse drug reactionStatisticsHypersensitivityAdvocacy group

